SEM - Select Medical Holdings Corporation... | Finranks

SEM - Select Medical Holdings Corporation... | Finranks

SEM Shareholder Buyout Investigation Launched by Kaskela Law: Does $16.50 Per Share Buyout Proposal Shortchange Select Medical Shareholders?

SEM Shareholder Buyout Investigation Launched by Kaskela Law: Does $16.50 Per Share Buyout Proposal Shortchange Select Medical Shareholders?

Kaskela Law is investigating the fairness of the $16.50 per share Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholder buyout.

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company's investors or if it undervalues the company's shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr.

Select Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Select Medical Holdings Corporation - SEM

Select Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Select Medical Holdings Corporation - SEM

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors. Under the terms of the proposed transaction, shareholders of Select Medical will receive $16.50 in cash for each share of Select Medical that they own. KSF is seeking to determine whether.

SEM's $16.50 Take-Private Moment: Undervalued or Perfectly Timed?

SEM's $16.50 Take-Private Moment: Undervalued or Perfectly Timed?

Select Medical jumps 8.4% on a $16.50-per-share take-private deal, but with analyst targets higher, investors may question if the timing leaves upside on the table.

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Select Medical Holdings Corporation (NYSE: SEM)

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Select Medical Holdings Corporation (NYSE: SEM)

NEW YORK, March 3, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Select Medical Holdings Corporation (NYSE: SEM ) related to its sale to a consortium led by Select Medical executives and directors.

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Select Medical Holdings Corporation (NYSE - SEM)

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Select Medical Holdings Corporation (NYSE - SEM)

BALA CYNWYD, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Select Medical Holdings Corporation (“Select Medical” or the “Company”) (NYSE - SEM) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to a consortium of entities, including Robert A. Ortenzio, Executive Chairman, Co-Founder and Director of Select Medical for $16.50 per share in cash, representing an enterprise value of $3.9 billion.

SEM Stock Alert: Halper Sadeh LLC is Investigating Whether Select Medical Holdings Corporation is Obtaining a Fair Price for its Shareholders

SEM Stock Alert: Halper Sadeh LLC is Investigating Whether Select Medical Holdings Corporation is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Select Medical Holdings Corporation (NYSE: SEM) to a consortium led by Select Medical executives and directors for $16.50 in cash per share. Halper Sadeh encourages Select Medical shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected]. The investigatio.

Videos

No Data

There is no data to display